92 related articles for article (PubMed ID: 9454807)
1. Regulation of K+ and Ca++ channels by a family of neuropeptide Y receptors.
Sun L; Philipson LH; Miller RJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):625-32. PubMed ID: 9454807
[TBL] [Abstract][Full Text] [Related]
2. Receptors for neuropeptide Y, gamma-aminobutyric acid and dopamine differentially regulate Ca2+ currents in Xenopus melanotrope cells via the G(i) protein beta/gamma-subunit.
Zhang H; Roubos EW; Jenks BG; Scheenen WJ
Gen Comp Endocrinol; 2006 Jan; 145(2):140-7. PubMed ID: 16214143
[TBL] [Abstract][Full Text] [Related]
3. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
5. Multiple neuropeptide Y receptors regulate K+ and Ca2+ channels in acutely isolated neurons from the rat arcuate nucleus.
Sun L; Miller RJ
J Neurophysiol; 1999 Mar; 81(3):1391-403. PubMed ID: 10085364
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors.
Alvaro AR; Rosmaninho-Salgado J; Ambrósio AF; Cavadas C
J Neurochem; 2009 Jun; 109(5):1508-15. PubMed ID: 19344373
[TBL] [Abstract][Full Text] [Related]
7. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Iyengar S; Li DL; Simmons RM
J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
Fu LY; Acuna-Goycolea C; van den Pol AN
J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
[TBL] [Abstract][Full Text] [Related]
9. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
10. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and pancreatic polypeptide reduce calcium currents in acutely dissociated neurons from adult rat superior cervical ganglia.
Foucart S; Bleakman D; Bindokas VP; Miller RJ
J Pharmacol Exp Ther; 1993 May; 265(2):903-9. PubMed ID: 8098766
[TBL] [Abstract][Full Text] [Related]
12. Inwardly rectifying and voltage-gated outward potassium channels exhibit low sensitivity to methylmercury.
Yuan Y; Otero-Montañez JK; Yao A; Herden CJ; Sirois JE; Atchison WD
Neurotoxicology; 2005 Jun; 26(3):439-54. PubMed ID: 15935214
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus.
Acuna-Goycolea C; Tamamaki N; Yanagawa Y; Obata K; van den Pol AN
J Neurosci; 2005 Aug; 25(32):7406-19. PubMed ID: 16093392
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Adewale AS; Macarthur H; Westfall TC
Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry.
Qian J; Colmers WF; Saggau P
J Neurosci; 1997 Nov; 17(21):8169-77. PubMed ID: 9334392
[TBL] [Abstract][Full Text] [Related]
19. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]